Urinary Eicosanoid Metabolites in HIV-Infected Women with Central Obesity Switching to Raltegravir: An Analysis from the Women, Integrase, and Fat Accumulation Trial

Association between Urinary Prostaglandin E2 Metabolite and Breast Cancer Risk: A Prospective, Case-Cohort Study of Postmenopausal Women

(2013) S. Kim et al.   Cancer Prevention Research

Decreases in Inflammatory and Coagulation Biomarkers Levels in HIV-Infected Patients Switching from Enfuvirtide to Raltegravir: ANRS 138 Substudy

(2013) Erika F. Silva et al.   JOURNAL OF INFECTIOUS DISEASES

Efficacy and safety of raltegravir for treatment of HIV for 5 years in the BENCHMRK studies: final results of two randomised, placebo-controlled trials

(2013) Joseph J Eron et al.   LANCET INFECTIOUS DISEASES

In vivo platelet activation and platelet hyperreactivity in abacavir-treated HIV-infected patients

(2013) Barbara Belfiori et al.   THROMBOSIS AND HAEMOSTASIS

A Randomized Trial of Raltegravir Replacement for Protease Inhibitor or Non-Nucleoside Reverse Transcriptase Inhibitor in HIV-Infected Women with Lipohypertrophy

(2012) Jordan E. Lake et al.   AIDS PATIENT CARE AND STDS

Major metabolite of F2-isoprostane in urine may be a more sensitive biomarker of oxidative stress than isoprostane itself

(2012) Tsogzolmaa Dorjgochoo et al.   AMERICAN JOURNAL OF CLINICAL NUTRITION

Measurement of F2- isoprostanes and isofurans using gas chromatography–mass spectrometry

(2012) Ginger L. Milne et al.   FREE RADICAL BIOLOGY AND MEDICINE

Sex differences in urinary biomarkers of vascular and endothelial function in HIV-infected persons receiving antiretroviral therapy

(2011) Michael S Boger et al.   ANTIVIRAL THERAPY

The Effect of HIV and HPV Coinfection on Cervical COX-2 Expression and Systemic Prostaglandin E2 Levels

(2011) D. W. Fitzgerald et al.   Cancer Prevention Research

Urinary Prostaglandin E2 Metabolite and Risk for Colorectal Adenoma

(2011) M. J. Shrubsole et al.   Cancer Prevention Research

No Risk of Myocardial Infarction Associated With Initial Antiretroviral Treatment Containing Abacavir: Short and Long-Term Results from ACTG A5001/ALLRT

(2011) H. J. Ribaudo et al.   CLINICAL INFECTIOUS DISEASES

HIV infection, body composition changes and related metabolic complications: contributing factors and evolving management strategies

(2011) Julian Falutz   CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE

Increased Platelet Reactivity in HIV-1–Infected Patients Receiving Abacavir-Containing Antiretroviral Therapy

(2011) Claudette S. Satchell et al.   JOURNAL OF INFECTIOUS DISEASES

Prevalence and Impact of Body Physical Changes in HIV Patients Treated with Highly Active Antiretroviral Therapy: Results from a Study on Patient and Physician Perceptions

(2010) Esther Cabrero et al.   AIDS PATIENT CARE AND STDS

Intra-Person Variation of Urinary Biomarkers of Oxidative Stress and Inflammation

(2010) X. Wu et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Increased plasma isoprostane is associated with visceral fat, high molecular weight adiponectin, and metabolic complications in obese children

(2010) Shunsuke Araki et al.   EUROPEAN JOURNAL OF PEDIATRICS

Markers of Inflammation, Coagulation, and Renal Function Are Elevated in Adults with HIV Infection

(2010) Jacqueline Neuhaus et al.   JOURNAL OF INFECTIOUS DISEASES

Switch to a raltegravir-based regimen versus continuation of a lopinavir-ritonavir-based regimen in stable HIV-infected patients with suppressed viraemia (SWITCHMRK 1 and 2): two multicentre, double-blind, randomised controlled trials

(2010) Joseph J Eron et al.   LANCET

Interaction between oxidative stress and high-density lipoprotein cholesterol is associated with severity of coronary artery calcification in rheumatoid arthritis

(2010) Young Hee Rho et al.   ARTHRITIS CARE & RESEARCH

Metabolic outcomes in a randomized trial of nucleoside, nonnucleoside and protease inhibitor-sparing regimens for initial HIV treatment

(2009) Richard H Haubrich et al.   AIDS

Urinary Prostaglandin E2 Metabolite and Gastric Cancer Risk in the Shanghai Women's Health Study

(2009) L. M. Dong et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Elevated Levels of Urinary Prostaglandin E Metabolite Indicate a Poor Prognosis in Ever Smoker Head and Neck Squamous Cell Carcinoma Patients

(2009) V. D. Kekatpure et al.   Cancer Prevention Research

Clinical Factors Associated with Plasma F2-Isoprostane Levels in HIV-Infected Adults

(2009) Leigh Anne Redhage et al.   HIV CLINICAL TRIALS

Nonconcordance between subclinical atherosclerosis and the calculated Framingham risk score in HIV-infected patients: relationships with serum markers of oxidation and inflammation

(2009) S Parra et al.   HIV MEDICINE

Safety and efficacy of raltegravir-based versus efavirenz-based combination therapy in treatment-naive patients with HIV-1 infection: a multicentre, double-blind randomised controlled trial

(2009) Jeffrey L Lennox et al.   LANCET

Contribution of Metabolic and Anthropometric Abnormalities to Cardiovascular Disease Risk Factors

(2008) Carl Grunfeld et al.   CIRCULATION

The Associations of Regional Adipose Tissue With Lipid and Lipoprotein Levels in HIV-Infected Men

(2008) David Wohl et al.   JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES

Regional Adipose Tissue and Lipid and Lipoprotein Levels in HIV-Infected Women

(2008) Judith Currier et al.   JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES

Endothelial Function in Human Immunodeficiency Virus-Infected Antiretroviral-Naive Subjects Before and After Starting Potent Antiretroviral Therapy

(2008) Francesca J. Torriani et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Use of nucleoside reverse transcriptase inhibitors and risk of myocardial infarction in HIV-infected patients enrolled in the D:A:D study: a multi-cohort collaboration

(2008)   LANCET

Oxidative Stress Is Associated With Arterial Dysfunction and Enhanced Intima-Media Thickness in Children With Hypercholesterolemia: The Potential Role of Nicotinamide-Adenine Dinucleotide Phosphate Oxidase

(2008) F. Martino et al.   PEDIATRICS